Axon Enterprise (AXON)
(Delayed Data from NSDQ)
$404.51 USD
+5.29 (1.33%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $404.53 +0.02 (0.00%) 7:14 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$404.51 USD
+5.29 (1.33%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $404.53 +0.02 (0.00%) 7:14 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Zacks News
Axovant Sciences (AXON) Shows Strength: Stock Jumps 9.2%
by Debasmita Banerjee
Axovant Sciences Ltd. (AXON) shares rose a little above 9% in the last trading session.
Is the Options Market Predicting a Spike in Axovant Sciences (AXON) Stock?
by Zacks Equity Research
Options traders are pricing in a big move for Axovant Sciences (AXON) shares as it has huge implied volatility.
The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant Sciences
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant Sciences
Implied Volatility Surging for Axovant Sciences (AXON) Stock Options
by Zacks Equity Research
Axovant Sciences (AXON) warrants investors' attention based on moves in the options market lately.